Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 29, 2018 - Issue 7
Submit an article Journal homepage
242
Views
2
CrossRef citations to date
0
Altmetric
Surgery and oncology

The efficacy and safety of methotrexate versus interferon in cutaneous T-cell lymphomas

Thevaki WainDepartment of Dermatology, Westmead Hospital, Sydney, Australia; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-6769-9675
ORCID Icon,
Alexandra PavliDepartment of Dermatology, Westmead Hospital, Sydney, Australia;
,
Jillian WellsDepartment of Dermatology, Westmead Hospital, Sydney, Australia;
&
Pablo Fernandez-PeñasDepartment of Dermatology, Westmead Hospital, Sydney, Australia; ;Sydney Medical School, University of Sydney, Sydney, AustraliaORCID Iconhttp://orcid.org/0000-0003-4882-1564
ORCID Icon
Pages 715-719 | Received 21 Dec 2017, Accepted 10 Feb 2018, Published online: 25 Feb 2018

References

  • Zackheim HS, Kashani-Sabet M, Hwang ST. Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: results in twenty-nine patients. J Am Acad Dermatol. 1996;34:626–631.
  • Zackheim HS, Kashani-Sabet M, McMillan A. Low-dose methotrexate to treat mycosis fungoides: a retrospective study in 69 patients. J Am Acad Dermatol. 2003;49:873–878.
  • McDonald CJ, Bertino JR. Treatment of mycosis fungoides lymphoma: effectiveness of infusions of methotrexate followed by oral citrovorum factor. Cancer Treat Rep. 1978;62:1009–1014.
  • Schappell DL, Alper JC, McDonald CJ. Treatment of advanced mycosis fungoides and Sézary syndrome with continuous infusions of methotrexate followed by fluorouracil and leucovorin rescue. Arch Dermatol. 1995;131:307–313.
  • Olsen EA. The pharmacology of methotrexate. J Am Acad Dermatol. 1991;25:306–318.
  • Olsen EA. Interferon in the treatment of cutaneous T-cell lymphoma. Dermatol Ther. 2003;16:311–321.
  • Olsen EA, Bunn PA. Interferon in the treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am. 1995;9:1089–1107.
  • Olsen EA, Rosen ST, Vollmer RT, et al. Interferon alfa-2a in the treatment of cutaneous T cell lymphoma. J Am Acad Dermatol. 1989;20:395–407.
  • Jawed SI, Myskowski PL, Horwitz S, et al. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome) Part II. Prognosis, management, and future directions. J Am Acad Dermatol. 2014;70:223e1–22e17.
  • Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007;110:1713–1722.
  • Vonderheid EC, Bernengo MG, Burg G, et al. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol. 2002;46:95–106.
  • Ross C, Tingsgaard P, Jørgensen H, et al. Interferon treatment of cutaneous T-cell lymphoma. Eur J Haematol. 1993;53:63–72.
  • Spaccarelli N, Rook AH. The use of interferons in the treatment of cutaneous T-cell lymphoma. Dermatol Clin. 2015;33:731–745.
  • Kannangara AP, Levitan D, Fleischer AB, Jr. Evaluation of the efficacy of the combination of oral bexarotene and methotrexate for the treatment of early stage treatment-refractory cutaneous T-cell lymphoma. J Dermatolog Treat. 2009;20:169–176.
  • Stadler R, Otte HG, Luger T, et al. Prospective randomized multicenter clinical trial on the use of interferon a-2a plus acitretin versus interferon a-2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II. Blood. 1998;92:3578–3581.
  • Nikolaou V, Siakantaris MP, Vassilakopoulos TP, et al. PUVA plus interferon a2b in the treatment of advanced or refractory to PUVA early stage mycosis fungoides: a case series. J Eur Acad Dermatol Venereol. 2011;25:354–357.
  • Abbott RA, Whittaker SJ, Morris SL, et al. Bexarotene therapy for mycosis fungoides and Sézary syndrome. Br J Dermatol. 2009;160:1299–1307.
  • Gniadecki R, Assaf C, Bagot M, et al. The optimal use of bexarotene in cutaneous T-cell lymphoma. Br J Dermatol. 2007;157:433–440.
  • Foss FM. Evaluation of the pharmacokinetics, preclinical and clinical efficacy of pralatrexate for the treatment of T-cell lymphoma. Exp Opin Drug Metabol Toxicol. 2011;7:1141–1152.
  • Knobler R, Duvic M, Querfeld C, et al. Long-term follow-up and survival of cutaneous T-cell lymphoma patients treated with extracorporeal photopheresis. Photodermatol Photoimmunol Photomed. 2012;28:250–257.
  • Querfeld C, Rosen ST, Kuzel TM, et al. Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy. Arch Dermatol. 2005;141:305–311.
  • Duvic M, Olsen EA, Breneman D, et al. Evaluation of the long-term tolerability and clinical benefit of vorinostat in patients with advanced cutaneous T-cell lymphoma. Clin Lymphoma Myeloma. 2009;9:412–416.
  • Whittaker SJ, Demierre MF, Kim EJ, et al. Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma. JCO. 2010;28:4485–4491.
  • Kennedy GA, Seymour JF, Wolf M, et al. Treatment of patients with advanced mycosis fungoides and Sézary syndrome with alemtuzumab. Eur J Haematol. 2003;71:250–256.
  • Duvic M, Geskin L, Prince HM. Duration of response in cutaneous T-cell lymphoma patients treated with denileukin diftitox: results from 3 phase III studies. Clin Lymphoma Myeloma Leuk. 2013;13:377–384.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.